Home/Filings/4/0001144204-18-014203
4//SEC Filing

MARSHBANKS TRACY 4

Accession 0001144204-18-014203

CIK 0001023024other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 7:26 PM ET

Size

9.8 KB

Accession

0001144204-18-014203

Insider Transaction Report

Form 4
Period: 2018-03-08
Transactions
  • Sale

    Common Stock

    2018-03-09$63.01/sh36,561$2,303,709497,982 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-03-08$63.08/sh15,391$970,864534,543 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-03-12$63.03/sh12,269$773,315485,713 total(indirect: See Footnote)
Footnotes (4)
  • [F1]This transaction was executed in multiple trades at prices ranging from $63.00 to $63.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $63.00 to $63.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $63.00 to $63.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]Held by FA Private Equity Fund IV, L.P., FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, The Productivity Fund IV Liquidating Trust, and The Productivity Fund IV Advisors Fund Liquidating Trust, which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1)

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1
  • filerCIK 0001579618

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 7:26 PM ET
Size
9.8 KB